Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.5%.

  • Centessa Pharmaceuticals' Return on Invested Capital fell 800.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.55% for FY2024, which is 300.0% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Return on Invested Capital of 0.5% as of Q3 2025, which was down 800.0% from 0.44% recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Return on Invested Capital registered a high of 0.4% during Q1 2025, and its lowest value of 0.66% during Q1 2023.
  • For the 4-year period, Centessa Pharmaceuticals' Return on Invested Capital averaged around 0.53%, with its median value being 0.57% (2023).
  • Data for Centessa Pharmaceuticals' Return on Invested Capital shows a peak YoY increase of 2000bps (in 2025) and a maximum YoY decrease of -800bps (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows Centessa Pharmaceuticals' Return on Invested Capital stood at 0.6% in 2022, then increased by 1bps to 0.59% in 2023, then skyrocketed by 32bps to 0.4% in 2024, then fell by -24bps to 0.5% in 2025.
  • Its Return on Invested Capital was 0.5% in Q3 2025, compared to 0.44% in Q2 2025 and 0.4% in Q1 2025.